Frontlight ResearchEarly access
Trial site
EvergreenHealth Medical Center
- 7running trials
- 4closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease2 trials
- Cervical cancer1 trial
- Childhood cancers1 trial
- Chronic myeloid leukaemia1 trial
- Colorectal cancer1 trial
- Head and neck cancer1 trial
- Kidney cancer1 trial
- Lung cancer1 trial
- Mantle cell lymphoma1 trial
- Multiple sclerosis1 trial
- Myelodysplastic syndromes1 trial
- Neuroendocrine tumours1 trial
- Phase
- Phase 39 trials
- Phase 22 trials
- Status
- Active, not recruiting5 trials
- Completed4 trials
- Recruiting2 trials
- Lead sponsor
- National Cancer Institute (NCI)4 trials
- Bristol-Myers Squibb1 trial
- Celgene1 trial
- Eastern Cooperative Oncology Group1 trial
- Eli Lilly and Company1 trial
- and 3 more
Running trials
Recruiting
Recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease1 recruiting
- Multiple sclerosis1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026